Preventive Strategies against Bleeding due to Nonvitamin K Antagonist Oral Anticoagulants

Dabigatran etexilate (DE), rivaroxaban, and apixaban are nonvitamin K antagonist oral anticoagulants (NOACs) that have been compared in clinical trials with existing anticoagulants (warfarin and enoxaparin) in several indications for the prevention and treatment of thrombotic events. All NOACs prese...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sarah, Lessire, Anne-Sophie, Dincq, Jonathan, Douxfils, Bérangère, Devalet, Jean-Baptiste, Nicolas, Anne, Spinewine, Anne-Sophie, Larock, Jean-Michel, Dogné, Maximilien, Gourdin, François, Mullier
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2014
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4084591/
https://ncbi.nlm.nih.gov/pubmed/25032218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/616405
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky